Purchase Order N6809620P0046
Award Date 8/28/20
Potential Completion Date 9/1/21
Potential Value $224K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Agana Heights, Guam
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed price purchase order to Medpharm, Inc. doing business as Procara, a minority-owned small business, for the purchase of BioFire consumables for a laboratory department. The $171,691.60 contract has a completion date of September 15, 2023. Procara has a history of providing medical and laboratory supplies, equipment, and services to the Department of Defense as a prime contractor, including reagents, test kits, and...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed price delivery order contract to Medpharm, Inc. doing business as Procara, a minority-owned small disadvantaged business. The $103,090.50 award is for the provision of a hematology laboratory analyzer and associated consumables, reagents, and maintenance services. The place of performance is at a U.S. military medical facility in Guam. Procara has a history of providing critical medical products and equipment to...
- The Defense Health Agency awarded a firm fixed price purchase order to Medpharm, Inc. (doing business as Procara), a minority-owned small business, for the lease of two Vitek Compact Max2 analyzers and the supply of associated reagents. The total potential value of the contract is $153,955.27. This requirement was designated as a total small business set-aside. Procara has a history of providing medical products and equipment maintenance services to the Department of Defense, including...
- The Defense Health Agency awarded a purchase order to Medpharm Inc. (doing business as Procara), a minority-owned small disadvantaged business and Asian-Pacific American-owned enterprise, for $1,455,315.95 on December 13, 2024. The order carries a total small business set-aside designation. Work is performed in Yigo, Guam, and covers coagulation reagents, consumables, maintenance, and lease of two Stago Compact MAX3 coagulation analyzer units for Naval Hospital Guam's laboratory operations....
- This federal contract award, valued at $76,871.42, was made by the U.S. Department of Defense's Bureau of Medicine and Surgery (BUMED) to Medpharm, Inc., doing business as Procara. Procara is a minority-owned small disadvantaged business that specializes in providing medical equipment, supplies, and services to the U.S. federal government. The contract is for the service and lease of medical equipment, with a period of performance ending on September 30, 2016. It is a firm fixed-price purchase...
- The Defense Health Agency awarded a $225,000 firm fixed-price purchase order to Medpharm, Inc. (doing business as Procara) on September 27, 2024, for the lease and maintenance of Biomerieux Vitek 2 Compact Analyzers at U.S. Naval Hospital Guam in Agana Heights, Guam. The contract, which extends through September 30, 2027, encompasses the provision of two analyzers capable of performing microbial identification and antibiotic susceptibility testing, along with comprehensive on-site preventative...
- This is a $144,530.00 firm fixed-price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery to Procara, a minority-owned small disadvantaged business based in Guam. The contract is for preventive maintenance services and does not have a set-aside designation. Procara has a history of supporting U.S. military medical facilities in the Pacific region, providing a range of medical equipment, supplies, and associated services. This award is part of Procara's portfolio of federal...
- This firm fixed price purchase order was awarded by the Defense Health Agency to Biofire Defense LLC for $365,226. The contract calls for the delivery of 90 Biofire Respiratory Panel 2.1 in vitro diagnostic test kits to aid the Department of Defense's response to the COVID-19 pandemic. Per the terms, Biofire will ship 45 kits on May 18, 2022 and the remaining 45 kits on September 14, 2022 to the Naval Medical Center in San Diego. The original solicitation sought quotes for the 90 Biofire RP2.1...
- The Bureau of Medicine and Surgery awarded a $102,344 firm fixed-price purchase order to Biofire Defense LLC on July 22, 2024, for FilmArray Respiratory Panels 2.1. The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2025, with performance taking place in Peru. Biofire Defense LLC, a Salt Lake City-based limited liability company specializing in molecular diagnostic technologies, has established itself as a key federal vendor for infectious...
- This federal contract award, with ID N6264519P0076, was made by the Bureau of Medicine and Surgery (BUMED), a Defense agency, to Biofire Defense LLC, a for-profit limited liability company. The $78,492.00 firm fixed-price purchase order is for the delivery of "GLOBAL FEVER PANELS (INCREMENT #1)" and has an ultimate completion date of February 5, 2020. Biofire Defense is a manufacturer of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II...